| Small-molecule XIAP inhibitors enhance γ-irradiation-induced apoptosis in glioblastoma SHK Vellanki, A Grabrucker, S Liebau, C Proepper, A Eramo, V Braun, ... Neoplasia 11 (8), 743-W9, 2009 | 148 | 2009 |
| Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis T Unterkircher, S Cristofanon, SHK Vellanki, L Nonnenmacher, ... Clinical Cancer Research 17 (12), 4019-4030, 2011 | 115 | 2011 |
| Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP A Bangert, S Cristofanon, I Eckhardt, BA Abhari, S Kolodziej, S Häcker, ... Oncogene 31 (44), 4677-4688, 2012 | 109 | 2012 |
| The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair MA Westhoff, JA Kandenwein, S Karl, SHK Vellanki, V Braun, A Eramo, ... Oncogene 28 (40), 3586-3596, 2009 | 100 | 2009 |
| NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma Cells for γ-irradiation–induced apoptosis R Berger, C Jennewein, V Marschall, S Karl, S Cristofanon, L Wagner, ... Molecular cancer therapeutics 10 (10), 1867-1875, 2011 | 96 | 2011 |
| Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition S Giagkousiklidis, SH Vellanki, KM Debatin, S Fulda Oncogene 26 (49), 7006-7016, 2007 | 78 | 2007 |
| Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings AO Leech, SHK Vellanki, EJ Rutherford, A Keogh, H Jahns, L Hudson, ... Breast Cancer Research 20, 1-18, 2018 | 40 | 2018 |
| Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth SHK Vellanki, RGB Cruz, H Jahns, L Hudson, G Sette, A Eramo, ... Cancer letters 440, 23-34, 2019 | 28 | 2019 |
| Antibiotic tetrocarcin-A down-regulates JAM-A, IAPs and induces apoptosis in triple-negative breast cancer models SH Vellanki, RGB Cruz, CE Richards, YE Smith, L Hudson, H Jahns, ... Anticancer research 39 (3), 1197-1204, 2019 | 18 | 2019 |
| Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species CE Richards, SH Vellanki, YE Smith, AM Hopkins Cellular Oncology 41, 35-46, 2018 | 17 | 2018 |
| Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk YE Smith, SHK Vellanki, AM Hopkins World Journal of Biological Chemistry 7 (1), 64, 2016 | 17 | 2016 |
| Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers M Milewska, M Cremona, C Morgan, J O’Shea, A Carr, SHK Vellanki, ... Therapeutic Advances in Medical Oncology 10, 1758834017746040, 2018 | 13 | 2018 |
| The Contribution of Ig-Superfamily and MARVEL D Tight Junction Proteins to Cancer Pathobiology SHK Vellanki, CE Richards, YE Smith, AM Hopkins Current Pathobiology Reports 4, 37-46, 2016 | 1 | 2016 |
| Determination of single cell surface protein expression using a tagless microfluidic method R Kumar, SHK Vellanki, R Smith, R Wieder Lab on a Chip 12 (9), 1646-1655, 2012 | 1 | 2012 |
| Science Repository SHK Vellanki, V Bustos, BJ Harvey, AM Hopkins | | 2019 |
| Natural antibiotic Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumour cell growth SH Vellanki, R Cruz, H Jahns, L Hudson, G Sette, A Eramo, A Hopkins EUROPEAN JOURNAL OF CANCER 103, E88-E88, 2018 | | 2018 |
| An old foe with a new function: JAM-A regulates expression of EphB4 and inhibitor of apoptosis proteins in breast cancer SHK Vellanki, RG Cruz, CE Richards, K Brennan, AM Hopkins Cancer Research 78 (13_Supplement), 4025-4025, 2018 | | 2018 |
| Natural compound tetrocarcin-A downregulates junctional adhesion molecule-A in conjunction with erα, her2 and inhibitor of apoptosis proteins and inhibits tumor cell growth SH Vellanki, L Hudson, H Jahns, RGB Cruz, G Sette, A Eramo, ... Cancer Research 78 (13_Supplement), 2670-2670, 2018 | | 2018 |
| Tumor dormancy in breast cancer cells: Identification of junctional adhesion molecule-A as a novel regulator SHK Vellanki, RG Cruz, KM Sheehan, EW Kay, AM Hopkins Cancer Research 78 (13_Supplement), 54-54, 2018 | | 2018 |
| PO-444 The emerging role of junctional adhesion molecule-A (JAM-A) as a novel drug target in ductal carcinoma in situ (DCIS) YE Smith, K Brennan, L Hudson, SH Vellanki, AO Leech, H Jahns, ... ESMO Open 3, A405-A406, 2018 | | 2018 |
